Autotelicbio
Clinical trials sponsored by Autotelicbio, explained in plain language.
-
New drug ATB-320 enters first human safety trial for Hard-to-Treat cancers
Disease control Not yet recruitingThis early-stage trial tests the safety of a new drug called ATB-320 in 24 adults with advanced solid tumors that have spread or stopped responding to standard treatments. The main goal is to find the highest safe dose and identify any side effects. Participants will receive the …
Phase: PHASE1 • Sponsor: Autotelicbio • Aim: Disease control
Last updated May 18, 2026 12:12 UTC
-
New combo pill for diabetes and hypertension put to the test
Knowledge-focused Not yet recruitingThis early-stage study tests whether a new tablet that combines two medicines (for type 2 diabetes and high blood pressure) works as well as taking the two medicines separately. Healthy adult volunteers will receive single doses of each version in a random order, and researchers …
Phase: PHASE1 • Sponsor: Autotelicbio • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC